The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study
Authored by Brandon D L Marshall, Sandro Galea, Daniel J Escudero, Mark N Lurie, Kenneth H Mayer, Maximilian King, Samuel R Friedman
Date Published: 2017
DOI: 10.1186/s12889-017-4528-9
Sponsors:
No sponsors listed
Platforms:
No platforms listed
Model Documentation:
Other Narrative
Model Code URLs:
Model code not found
Abstract
Background: People who inject drugs (PWID) are at continued risk for HIV
in the U.S., and experience disparities across the HIV care continuum
compared to other high-risk groups. Estimates of the risk of HIV
transmission at each stage of the care continuum may assist in
identifying public health priorities for averting incident infections
among PWID, in addition to transmissions to sexual partners of PWID.
Methods: We created an agent-based model simulating HIV transmission and
the HIV care continuum for PWID in New York City (NYC) in 2012. To
account for sexual transmission arising from PWID to non-PWID, the
simulation included the entire adult NYC population. Using surveillance
data and estimates from the National HIV Behavioral Surveillance system,
we simulated a dynamic sexual and injecting network. We estimated the
proportion of HIV transmission events attributable to PWID in the
following categories, those: without an HIV diagnosis (`Undiagnosed');
diagnosed but not on antiretroviral therapy (ART) (`Diagnosed-not on
ART'); those who initiated ART but were not virally suppressed
(`Unsuppressed'); and, those who achieved viral suppression
(`Suppressed').
Results: We estimated HIV incidence among PWID to be 113 per 100,000
person-years in 2012, with an overall incidence rate for the entire
adult NYC population of 33 per 100,000 person-years. Despite accounting
for only 33\% of the HIV-infected PWID population, the Undiagnosed were
associated with 52.6\% (95\% simulation interval [95\% SI]:
47.157.0\%) of total transmission events. The Diagnosed-not on ART
population contributed the second-largest proportion of HIV
transmissions, with 36.6\% (95\% SI: 32.2-41.5\%). The Unsuppressed
population contributed 8.7\% (95\% SI: 5.6-11.8\%), and Suppressed 2.1\%
(95\% SI: 1.1-3.9\%), relatively little of overall transmission.
Conclusions: Among PWID in NYC, more than half (53\%) of transmissions
were from those who were unaware of their infection status and more than
36\% were due to PWID who knew their status, but were not on treatment.
Our results indicate the importance of early diagnosis and interventions
to engage diagnosed PWID on treatment to further suppress
population-level HIV transmission. Future HIV prevention research should
focus on the elimination of identified and potential barriers to the
testing, diagnosis, and retention of PWID on HIV treatment.
Tags
Infection
HAART
United-states
Prevention
Metaanalysis
New-york-city
Antiretroviral therapy
Users
Men
People who inject drugs
Hiv care continuum
Hiv care cascade
Art
Sexual-behavior
Heroin use